First Tracks Biotherapeutics, Inc. (TRAX)
NASDAQ: TRAX · Real-Time Price · USD
17.79
+0.89 (5.27%)
May 18, 2026, 4:00 PM EDT - Market closed
TRAX Stock Forecast
Stock Price Forecast
The 7 analysts that cover TRAX stock have a consensus rating of "Strong Buy" and an average price target of $39.43, which forecasts a 121.64% increase in the stock price over the next year. The lowest target is $30 and the highest is $54.
Price Target: $39.43 (+121.64%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for TRAX stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '26 |
|---|---|
| Strong Buy | 2 |
| Buy | 4 |
| Hold | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Initiates $54 | Buy | Initiates | $54 | +203.54% | May 4, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $30 | Strong Buy | Initiates | $30 | +68.63% | Apr 28, 2026 |
| Leerink Partners | Leerink Partners | Buy Initiates $46 | Buy | Initiates | $46 | +158.57% | Apr 24, 2026 |
| JP Morgan | JP Morgan | Buy Initiates $31 | Buy | Initiates | $31 | +74.26% | Apr 23, 2026 |
| Barclays | Barclays | Buy Initiates $40 | Buy | Initiates | $40 | +124.85% | Apr 22, 2026 |
Financial Forecast
Revenue This Year
16.54M
Revenue Next Year
n/a
from 16.54M
EPS This Year
-2.91
EPS Next Year
-3.36
from -2.91
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 78.8M | n/a | ||
| Avg | 16.5M | n/a | ||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | - | - | ||
| Avg | - | - | ||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | -0.24 | -2.64 | ||
| Avg | -2.91 | -3.36 | ||
| Low | -3.85 | -4.05 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | - | - | ||
| Avg | - | - | ||
| Low | - | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.